Catalyst Funds Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Catalyst Funds Management's AMGN Position: Q2 2026 in Review
Catalyst Funds Management reduced its Amgen (AMGN) stake by 59% in Q2 2026, selling an estimated $497K and leaving 1,000 shares worth $362K. The position accounts for 0.02% of the portfolio, ranked #465.
Catalyst Funds Management first reported a position in AMGN in Q1 2024 and has held it in 8 quarters since. The position peaked at $863K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Catalyst Funds Management held 1,000 shares of Amgen worth $362K as of Q2 2026.
- Catalyst Funds Management sold 1,453 Amgen shares in Q2 2026, an estimated $497K.
- Amgen made up 0.02% of Catalyst Funds Management's portfolio in Q2 2026, its #465 holding.
- Catalyst Funds Management first reported a position in Amgen in Q1 2024 and has held it in 8 quarters since.
- Catalyst Funds Management's Amgen position peaked at $863K in Q1 2026.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.